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Abstract
Background: A reliable prediction of the causative agent of community-acquired pneumonia
(CAP) is not possible based on clinical features. Our aim was to test, whether the measurement of
the expression of complement receptors or Fcγ receptors on neutrophils and monocytes would
be a useful preliminary test to differentiate between bacterial and viral pneumonia.
Methods: Sixty-eight patients with CAP were studied prospectively. Thirteen patients had
pneumococcal pneumonia; 13 patients, influenza A pneumonia; 5 patients, atypical pneumonia, and
37 patients, aetiologically undefined pneumonia. Leukocyte receptor expression was measured
within 2 days of hospital admission.
Results: The mean expression of complement receptor 1 (CR1) on neutrophils was significantly
higher in the patients with pneumococcal pneumonia than in those with influenza A pneumonia.
The mean expression of CR1 was also significantly higher in aetiologically undefined pneumonia
than in influenza A pneumonia, but there was no difference between pneumococcal and undefined
pneumonia.
Conclusion: Our results suggest that the expression of CR1 is higher in classical bacterial
pneumonia than in viral pneumonia. Determination of the expression of CR1 may be of value as an
additional rapid tool in the aetiological diagnosis, bacterial or viral infection, of CAP. These results
are preliminary and more research is needed to assess the utility of this new method in the
diagnostics of pneumonia.
Background
Community-acquired pneumonia (CAP) is a common ill-
ness with a wide range of causative agents. The medical
history of the patient and the clinical findings may be sug-
gestive for the aetiology of CAP. In most cases, however, a
reliable prediction of the causative agent of CAP is not
possible on grounds of clinical features [1,2]. Neither are
the manifestations on a chest radiograph specific enough
for the aetiological diagnosis of CAP [2,3]. On admission,
it may even be difficult to differentiate between the bacte-
rial and viral aetiology of pneumonia. Although there is
some evidence suggesting that the serum C-reactive pro-
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by Streptococcus pneumoniae or Legionella pneumophila than
in those caused by other agents, the relation of CRP to the
aetiology of pneumonia is controversial [4-7].
Phagocytosis is an important part of the cellular defence
system to eliminate the extracellular microorganisms. The
first step in the phagocytosis is adherence of a particle
onto a phagocyte membrane via complement receptors
and/or Fc-receptors. The aim of the present study was to
examine, whether the measurement of the expression of
complement receptors (CR1 and CR3) and Fcγ-receptors
(FcγRI, FcγRII, and FcγRIII) on neutrophils or monocytes
would be of value in differentiating between bacterial and
viral pneumonia.
Methods
Sixty-eight immunocompetent adults admitted for CAP to
the Department of Medicine, Infectious Diseases Unit,
Turku University Hospital, Turku, Finland, were studied
prospectively. The diagnosis of pneumonia was based on
the presence of an infiltrate on chest radiograph in associ-
ation with fever and/or respiratory symptoms for which
no other cause was found. The diagnosis of pneumonia
was made by 2 of the authors (UH and PK) by consensus.
In addition, the chest X rays were examined by a specialist
in radiology.
The mean age of the patients was 53.7 years (range, 18 to
87 years). There were 41 males and 27 females. Underly-
ing diseases were present in 28 patients; COPD, cardiovas-
cular disease and alcoholism being the most common.
None of the patients needed mechanical ventilation or
treatment in the intensive care unit. All patients gave a
written consent, which was approved by the institutional
ethics committee.
For each patient, the microbiological examinations and
the treatment were carried out according to the routine
clinical practice [8,9]. Mycoplasma pneumoniae and
Chlamydia pneumoniae IgG and IgM antibodies were meas-
ured by commercial enzyme immunoassay kits (IgG-EIA,
and IgM-EIA, ThermoLabsystems, Helsinki, Finland) [10]
according to the instructions of the manufacturer; and
Legionella IgG and IgM antibodies, using a previously
described method, with L. pneumophila 1–4 and L. micda-
dei as antigens [11]. Serology for respiratory viruses (influ-
enza A and B viruses, adenovirus, respiratory syncytial,
parainfluenza virus types 1, 2 and 3) was done with anti-
gens prepared at the Department of Virology, University
of Turku, by enzyme immunoassay as described previ-
ously [12]. Viral antigens for respiratory viruses were
detected by time-resolved fluoroimmunoassay [13]. M.
pneumoniae polymerase chain reaction (PCR) test and
Legionella spp. PCR test were performed as described pre-
viously [14,15]. Unconcentrated urine samples were
tested using the immunochromatographic assay Binax
NOW S. pneumoniae antigen (Binax, Portland, Maine).
Table 1: Comparison of receptor expressions of neutrophils and monocytes in patients with Streptococcus pneumoniae, influenza A and 
aetiologically undefined pneumonia. P values for overall group differences tested using analysis of variance (ANOVA).
Parameter A 
S. pneumoniae 
(n = 13) 
B 
Influenza A 
(n = 13) 
C 
Undefined 
(n = 37) 
D 
Control 
(n = 63) 
p value
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
WBC (×109/l) 12.3 (6.9) 7.6 (2.2) 10.3 (4.2) 4.8 (1.3) <0.0001
PMNL (×109/l) 8.9 (4.4) 5.5 (2.3) 7.5 (3.6) 2.6 (0.9) <0.0001
CRP (mg/l) 370.0 (121.5) 108.2 (87.7) 179.7 (94.4) - <0.0001
ESR (mm/h) 79.4 (20.4) 39.1 (29.7) 69.2 (24.1) - 0.0018
Receptor expression of neutrophils
CR1 20.4 (9.8) 7.5 (4.6) 19.3 (8.8) 6.3 (2.2) <0.0001
CR3 63.1 (32.6) 80.7 (40.9) 107.2 (47.9) 48.5 (17.8) <0.0001
FcγRI 4.7 (2.5) 2.9 (2.5) 5.0 (5.3) 0.6 (0.3) <0.0001
FcγRII 12.8 (5.4) 10.3 (4.2) 13.0 (4.3) 11.0 (1.8) 0.0350
FCγRIII 89.6 (43.3) 111.7 (46.2) 120.3 (43.1) 128.0 (34.3) 0.0285
Receptor expression of monocytes
CR1 11.7 (4.5) 9.7 (5.0) 15.3 (6.7) 4.6 (2.7) <0.0001
CR3 63.9 (30.8) 84.6 (30.4) 109.8 (65.1) 44.6 (33.5) <0.0001
FcγRI 14.0 (3.7) 18.9 (4.5) 18.9 (8.7) 8.4 (1.9) <0.0001
FcγRII 13.1 (6.4) 18.5 (6.9) 18.7 (8.2) 11.7 (1.9) <0.0001
WBC = white blood cell count, PMNL = polymorphonuclear leukocyte count, CRP = serum C-reactive protein, ESR = erythrocyte sedimentation 
rate.Page 2 of 5
(page number not for citation purposes)
BMC Infectious Diseases 2006, 6:11 http://www.biomedcentral.com/1471-2334/6/11Isolation of S. pneumoniae from blood cultures or detec-
tion of pneumococcal capsular antigen in urine was con-
sidered diagnostic for S. pneumoniae. A 4-fold or greater
increase in serologic titres was considered diagnostic for
M. pneumoniae, C. pneumoniae, or L. pneumophila. Identifi-
cation of specific DNA for M. pneumoniae or L. pneu-
mophila in a throat swab or sputum sample made a
definitive causative diagnosis. Recognition of respiratory
viruses was based on the detection of viral antigen in the
nasopharyngeal sample or a 4-fold or greater increase in
serologic titres.
For the measurement of leukocyte receptor expression, 10
ml of heparin anticoagulated blood was collected from
the patients within 2 days of hospital admission. The pro-
cedure was performed as described previously using fluo-
rescence-labelled receptor-specific monoclonal
antibodies [16]. FITC-conjugated anti-FcγRI (CD64;
mouse IgG1 isotype, clone 22), anti-FcγRIII (CD16;
mouse IgG1 isotype, clone 3G8), anti-CR1 (CD35; mouse
IgG1 isotype, clone J3D3), and mouse IgG1 isotype con-
trol (clone 679.1Mc7) as well as PE-conjugated anti-
FcγRII (CD32; mouse IgG2a isotype, clone 2E1), anti-CR3
(CD11b; mouse IgG1 isotype, clone Bear1), mouse IgG1
isotype control (clone 679.1Mc7), and mouse IgG2a iso-
type control (clone U7.27) were purchased from Immu-
notech (Marseille, France). A relative measure of receptor
expression was obtained by determining the mean fluo-
rescence intensity (MFI) of 5000 leukocytes by flow
cytometer.
Concurrently with the collection of blood for the meas-
urement of leukocyte receptor expression, blood or
plasma samples were taken for the measurement of CRP,
erythrocyte sedimentation rate (ESR), and white blood
cell count (WBC). The expression of leukocyte receptors in
pneumonia patients was compared to the expression of
leukocyte receptors in 63 healthy controls. CRP and ESR
values were not analysed for the controls.
All data in Table 1 and box chart presentation (Figure) are
expressed as the mean (SD). In the box chart, 25%, 50%,
and 75% quartiles are also presented. First, the group dif-
ferences were tested using analysis of variance (ANOVA).
Pairwise, group comparisons after ANOVA were carried
out using Tukey's multiple comparison technique. A p-
value of less than 0.05 was considered significant.
Results
An aetiological agent was established in 30 of the 68
patients with CAP. Group A consisted of 13 patients with
S. pneumoniae infection (10 detected by blood culture, 3
by pneumococcal antigen test) and group B consisted of
13 patients with influenza A infection (11 identified by
viral antigen detection on the nasopharyngeal sample,
and 2 by serology). In group C, the aetiological agent of
the 37 patients remained unknown. Atypical pneumonia
was identified in 5 patients: 3 M. pneumoniae by serology,
1 C. pneumoniae by serology, and 1 L. pneumophila by PCR
and serology.
Table 2: Comparison of receptor expressions of neutrophils and monocytes in patients with Streptococcus pneumoniae, influenza A and 
aetiologically undefined pneumonia. Group comparisons after ANOVA carried out using Tukey's multiple comparison technique.
p value
Parameter A vs B A vs C B vs C A vs D B vs D C vs D
WBC (×109/l) 0.1052 0.7702 0.0243 0.0010 <0.0001 <0.0001
PMNL (×109/l) 0.0586 0.7265 0.0813 <0.0001 0.0001 <0.0001
CRP (mg/l) <0.0001 <0.0001 0.0417 - - -
ESR (mm/h) 0.0012 0.3333 0.0094 - - -
Receptor expression of neutrophils
CR1 0.0002 0.9836 <0.0001 <0.0001 0.8091 <0.0001
CR3 0.6191 0.0020 0.2263 0.3983 0.0307 <0.0001
FcγRI 0.2826 0.9935 0.2518 <0.0001 0.0053 <0.0001
FcγRII 0.5413 0.9998 0.2031 0.6273 0.9311 0.0431
FCγRIII 0.6049 0.1487 0.9358 0.0222 0.6231 0.7949
Receptor expression of monocytes
CR1 0.7146 0.1320 0.0100 <0.0001 0.0027 <0.0001
CR3 0.3126 0.0057 0.2553 0.1858 0.0002 <0.0001
FcγRI 0.0166 0.0308 1.0000 <0.0001 <0.0001 <0.0001
FcγRII 0.1630 0.0655 0.9999 0.8781 0.0033 <0.0001
WBC = white blood cell count, PMNL = polymorphonuclear leukocyte count, CRP = serum C-reactive protein, ESR = erythrocyte sedimentation 
rate, A = S. pneumoniae pneumonia, B = Influenza A pneumonia, C = Aetiologically undefined pneumonia, D = controls.Page 3 of 5
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pneumococcal or aetiologically undefined pneumonia
than in those with influenza A pneumonia (Tables 1 and
2). CRP was also significantly higher in pneumococcal
pneumonia than in aetiologically undefined pneumonia.
Total WBC was significantly lower in influenza A pneu-
monia than in aetiologically undefined pneumonia, but
there was no difference in WBC between influenza A
pneumonia and pneumococcal pneumonia.
The mean expression of CR1 on neutrophils was signifi-
cantly higher in the patients with pneumococcal pneumo-
nia than in those with influenza A pneumonia. The mean
expression of CR1 was also significantly higher in aetio-
logically undefined pneumonia than in influenza A pneu-
monia, but there was no difference between
pneumococcal and undefined pneumonia. Patients with
influenza A could be divided in 2 subgroups by the
expression of CR1 on neutrophils: 8 patients with CR1
ranging from 2.09 to 5.32 and 5 patients with CR1 rang-
ing from 11.1 to 15.5. The CRP values ranged from 44 to
178 mg/l and from 120 to 300 mg/l in these subgroups,
respectively. The expression of neutrophil CR1 in the
patients and controls is presented in the Figure.
The number of the patients with atypical pneumonia was
too small to be included in the statistical analysis. The
expression of CR1 ranged from 3.3 to 8.6 in the 3 patients
with M. pneumoniae infection, was 6.8 in the patient with
C. pneumoniae infection, and 33.6 in the patient with L.
pneumophila infection.
A significant difference in the expression of monocyte
FcγRI was observed between the patients with pneumo-
coccal and influenza A pneumonia, and in the expression
of monocyte CR1 between the patients with influenza A
and undefined pneumonia.
The results of the receptor expression of neutrophils and
monocytes of the patients and controls are presented in
Table 1.
Discussion
The main finding of the present study was that the expres-
sion of CR1 on neutrophils was significantly higher in the
patients with pneumococcal pneumonia than in those
with influenza A pneumonia. On a more general level,
this suggests that the expression of neutrophil CR1 is
higher in classical bacterial pneumonia than in viral pneu-
monia. The high level of CR1 in aetiologically undefined
pneumonia is consistent with this finding, since one can
speculate on epidemiological basis [1,17] that most of
these patients probably had bacterial pneumonia. In the
patients with M. pneumoniae and C. pneumoniae infection,
the expression of CR1 was low, though their number was
too small to allow any distinct conclusions to be drawn
from this finding. The subgroup of patients with influenza
A pneumonia, who had CR1 levels ≥ 11.1, is of note, but
could be explained by e.g. concomitant bacterial pneumo-
nia.
Also other significant differences were observed. The
expression of monocyte FcγRI was significantly higher in
the patients with influenza A pneumonia than in those
with pneumococcal pneumonia, but no difference was
found between influenza A and aetiologically unidenti-
fied pneumonia. On the other hand, the expression of
monocyte CR1 was significantly higher in the patients
with unidentified pneumonia than in those with influ-
enza A pneumonia, but no difference was found between
pneumococcal and influenza A pneumonia. Thus, these
results imply that the expression of neutrophil CR1 may
be associated with a better ability than that of the other
the neutrophil receptors, or of the monocyte receptors, to
differentiate between the bacterial and viral aetiology of
pneumonia.
The behaviour of CRP was similar to the expression of
neutrophil CR1 in that CRP was significantly higher in
pneumococcal and aetiologically undefined pneumonia
than in influenza A pneumonia. In a previous study by
García Vázquez et al. [5], however, the mean CRP values
were not significantly different among pneumonias
caused by agents other than L. pneumophila.
The expression of CR1 on neutrophils in patients with pneu-monia and contr lsFigure 1
The expression of CR1 on neutrophils in patients 
with pneumonia and controls. A: Streptococcus pneumo-
niae pneumonia; B: influenza A pneumonia; C: aetiologically 
undefined pneumonia; D: controls; E: atypical pneumonia.Page 4 of 5
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Although the high expression of neutrophil CR1 is sugges-
tive of classical bacterial pneumonia, it is unlikely that any
single parameter of inflammation alone could reliably dif-
ferentiate between bacterial and viral pneumonia. Rather,
it is possible that the diagnostic accuracy could be
improved by combination of the results of CRP, ESR, and
several cell receptors. Studies are presently underway to
determine, whether the diagnostic yield provided by the
measured individual variables would increase upon com-
bination.
Conclusion
Our results suggest that the expression of neutrophil CR1
is higher in classical bacterial pneumonia than in viral
pneumonia. Based on these findings, we suggest that
determination of the expression of CR1 on neutrophils
may be of value as an additional rapid tool in the aetio-
logical diagnosis, bacterial or viral infection, of CAP. Our
results are preliminary and more research is needed to
assess the utility of this new method in the diagnostics of
pneumonia.
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